Annree is a leadership consultant and an executive and team performance coach. She is an expert in medical affairs, advocacy, collaborative engagement excellence, organisational leadership, and interpersonal communication. She has worked successfully in the pharmaceutical industry for over 20 years, in a variety of positions with extensive experience in marketing, sales and medical affairs. She is passionate about unlocking the potential of people and optimising team health and performance. She forms long-term strategic partnerships with leaders to help them, their team and organisation win. She aligns her success with the KPIs that her clients are tasked to deliver. Annree brings her specialist skills and life experiences to help leaders and their teams win in every area of their life, both personally and professionally. Annree is Vice-Chair of the Board of Myeloma Australia. She is an Industry Mentoring Network in STEM (IMNIS) Mentor. She holds a Bachelor of Science (Genetics) from Trinity College Dublin, a Diploma in Marketing from Chartered Institute if Marketing and a Certificate in Health Technology Assessment from Sheffield University.

Dr. Linda Watson has been an oncology nurse in Calgary, Alberta, Canada for over 30 years. She has held a variety of nursing and inter-professional leadership roles within the Cancer Care Alberta (CCA) provincial program and is currently the Scientific Director within Alberta’s provincial cancer care program. Dr. Watson holds an adjunct professor position with the Faculty of Nursing at the University of Calgary, but her passion for improving the patient experience has kept her committed to her full-time position as an embedded researcher within the Alberta cancer system. Committed to enhancing the person centredness of the cancer system she has worked to design, implement and study new processes, systems, and programs to enhance clinical capacity to deliver tailored, individualized care to cancer patients. These include using Patient Reported Outcomes (PROs) to improve patient experience and outcomes, the implementation and evaluation of a provincial cancer patient navigation program to improve access for marginalized populations, and a provincial transition post-treatment program that aims to improve the transition between the cancer program and primary care, while also striving to improve survivors’ outcomes.

Mitchel has over 15 years of nursing experience having practiced in the areas of psychiatry, intensive care, oncology, and haematology. In 2012 Mitchel completed a Master of Nursing Science (MNSc) degree becoming a licensed acute care nurse practitioner. Since that time he has focused on the area of haematology previously working as a ward nurse practitioner in the USA, and now as the lymphoma nurse practitioner at the Alfred Hospital. In this role he provides expert clinical management of patients in the ambulatory setting; utilizing independent practice, interdisciplinary collaboration, and a patient centred care approach. Along with his clinical role, Mitchel engages frequently in unit and organizational change projects, research, and process improvement intiatives.

As above.

Hayley has 19 years experience working across haematology, oncology, bone marrow transplant and clinical trials. She has spent the majority of her time at the Royal Melbourne Hospital and spent 2 years working in Haematology Day Care at the University College London Hospital. Currently Hayley works as a Myeloma Clinical Nurse Consultant at the Peter MacCallum Cancer Centre and for the last 12 years, Hayley has shared her time in clinical roles with working at Myeloma Australia. Presently she is Head of Stakeholder Engagement. She is also the immediate past Victorian State Chair of the Haematology Society of Australia and New Zealand (HSANZ) Nurses’ Group. She has a passion for nurse-led research and is undertaking a Masters of Philosophy in Graduate Research.